PILOT--MODIFICATION OF MELANOMA CELLS WITH GPI-ANCHORED IL-2
PILOT--MODIFICATION OF MELANOMA CELLS WITH GPI-ANCHORED IL-2
批准号:
6235803
负责人:
Periasamy Selvaraj
金额:
$5.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-03-01 至 1998-02-28
关键词:
CHO cells cell membrane cellular immunity chimeric proteins flow cytometry immunization immunoaffinity chromatography interleukin 2 laboratory mouse melanoma membrane reconstitution /synthesis method development neoplasm /cancer immunology neoplasm /cancer immunotherapy neoplasm /cancer vaccine neoplastic cell nonhuman therapy evaluation phosphatidylinositols protein engineering protein purification transfection
中文摘要
许多研究表明,细胞因子在细胞凋亡中起主要作用。
恶性肿瘤如黑色素瘤的发病机制和治疗。系统性
在肿瘤患者中施用某些细胞因子已经显示,
增强肿瘤特异性免疫应答和某些肿瘤的消退
患者用细胞因子特异性基因转染的肿瘤已经被发现,
显示诱导肿瘤特异性免疫,表明肿瘤细胞
表达细胞因子将具有潜在的治疗价值,
疫苗。我们建议测试一种方法的有效性,
作为将细胞因子分子导入肿瘤的替代方案,
其中基因转染是不可行或不希望的。该方法
使用纯化的分子,可以在几个小时内完成,
合适的试剂。根据这项建议,我们将具体:
1.糖基磷脂酰肌醇(GPI)的构建、表达和纯化。
锚定IL-2;
2.确定黑色素瘤细胞是否用纯化的GPI重建,
IL-2可以诱导肿瘤特异性免疫。GPI锚定的细胞因子将是一种
替代现有的分子,因为它将不同于
母体分子在其自发结合到
疏水/两亲表面,如细胞膜。知识
从这个种子赠款提案中获得的将是巨大的价值,
制备用于治疗皮肤癌的免疫原性肿瘤细胞,
黑素瘤
英文摘要
Many studies have shown that cytokines play a major role in the
pathogenesis and cure of malignant tumors such as melanoma. Systemic
administration of certain cytokines in tumor patients have shown to
augment tumor specific immune responses and regression of tumors in some
patients. Tumors transfected with genes specific for cytokines have been
shown to induce tumor specific immunity suggesting that tumor cells
expressing cytokines will be of potential therapeutic value as tumor
vaccines. We propose to test the efficacy of a method that could be used
as an alternative for introduction of cytokine molecules onto tumors,
where gene transfection is not feasible or desirable. The proposed method
uses purified molecules and can be completed in a matter of hours with
appropriate reagents. Under this proposal specifically we will:
1. construct, express and purify glycosyl-phosphatidylinositol (GPI)-
anchored IL-2;
2. determine whether the melanoma cells reconstituted with purified GPI-
IL-2 can induce tumor specific immunity. GPI-anchored cytokines will be an
alternative to the existing molecules since it will be different from the
parent molecule in terms of its ability to spontaneously incorporate into
hydrophobic/amphiphilic surfaces such as cell membranes. The knowledge
obtained from this seed grant proposal will be of immense value in
preparing immunogenic tumor cells for treatment of skin cancers such as
melanoma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glycolipid-anchored cytokines as breast cancer membrane vaccine adjuvants
-
批准号:8459886
-
项目类别:
-
资助金额:$29.33万
-
财政年份:2009
-
负责人:Periasamy Selvaraj
-
依托单位:
Fc receptor targeted therapy for immune hemolytic anemia
-
批准号:7815744
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2009
-
负责人:Periasamy Selvaraj
-
依托单位:
Glycolipid-anchored cytokines as breast cancer membrane vaccine adjuvants
-
批准号:8066755
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2009
-
负责人:Periasamy Selvaraj
-
依托单位:
Glycolipid-anchored cytokines as breast cancer membrane vaccine adjuvants
-
批准号:8257491
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2009
-
负责人:Periasamy Selvaraj
-
依托单位:
Glycolipid-anchored cytokines as breast cancer membrane vaccine adjuvants
-
批准号:7735970
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2009
-
负责人:Periasamy Selvaraj
-
依托单位:
Recombinant Fc receptor therapeutics for systemic lupus erythematosus
-
批准号:7778229
-
项目类别:
-
资助金额:$17.26万
-
财政年份:2009
-
负责人:Periasamy Selvaraj
-
依托单位:
Recombinant Fc receptor therapeutics for systemic lupus erythematosus
-
批准号:7660806
-
项目类别:
-
资助金额:$20.93万
-
财政年份:2009
-
负责人:Periasamy Selvaraj
-
依托单位:
Fc receptor targeted therapy for immune hemolytic anemia
-
批准号:7558253
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2008
-
负责人:Periasamy Selvaraj
-
依托单位:
Fc receptor targeted therapy for immune hemolytic anemia
-
批准号:7356039
-
项目类别:
-
资助金额:$23.2万
-
财政年份:2008
-
负责人:Periasamy Selvaraj
-
依托单位:
Regulation of CD32A in neutrophils
-
批准号:6826289
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2002
-
负责人:Periasamy Selvaraj
-
依托单位:
Regulation of CD32A in neutrophils
-
批准号:6689994
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2002
-
负责人:Periasamy Selvaraj
-
依托单位:
Regulation of CD32A in neutrophils
-
批准号:7149177
-
项目类别:
-
资助金额:$28.82万
-
财政年份:2002
-
负责人:Periasamy Selvaraj
-
依托单位:
Regulation of CD32A in neutrophils
-
批准号:6573536
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2002
-
负责人:Periasamy Selvaraj
-
依托单位:
Regulation of CD32A in neutrophils
-
批准号:6984104
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2002
-
负责人:Periasamy Selvaraj
-
依托单位:
GPI-ANCHORED MOLECULES AS THERAPEUTIC VACCINES
-
批准号:2114630
-
项目类别:
-
资助金额:$14.76万
-
财政年份:1996
-
负责人:Periasamy Selvaraj
-
依托单位:
GPI-ANCHORED MOLECULES AS THERAPEUTIC VACCINES
-
批准号:2683653
-
项目类别:
-
资助金额:$19.32万
-
财政年份:1996
-
负责人:Periasamy Selvaraj
-
依托单位:
GPI-ANCHORED MOLECULES AS THERAPEUTIC VACCINES
-
批准号:2390932
-
项目类别:
-
资助金额:$18.54万
-
财政年份:1996
-
负责人:Periasamy Selvaraj
-
依托单位:
GPI-ANCHORED MOLECULES AS THERAPEUTIC VACCINES
-
批准号:2895542
-
项目类别:
-
资助金额:$19.45万
-
财政年份:1996
-
负责人:Periasamy Selvaraj
-
依托单位:
MEMBRANE ANCHORING AND FUNCTION OF CD16
-
批准号:2065797
-
项目类别:
-
资助金额:$11.52万
-
财政年份:1992
-
负责人:Periasamy Selvaraj
-
依托单位:
MEMBRANE ANCHORING AND FUNCTION OF CD16
-
批准号:3455711
-
项目类别:
-
资助金额:$9.88万
-
财政年份:1992
-
负责人:Periasamy Selvaraj
-
依托单位:
海外基金